全文获取类型
收费全文 | 29374篇 |
免费 | 2181篇 |
国内免费 | 98篇 |
专业分类
耳鼻咽喉 | 395篇 |
儿科学 | 969篇 |
妇产科学 | 531篇 |
基础医学 | 3554篇 |
口腔科学 | 313篇 |
临床医学 | 4007篇 |
内科学 | 5810篇 |
皮肤病学 | 328篇 |
神经病学 | 2888篇 |
特种医学 | 762篇 |
外国民族医学 | 7篇 |
外科学 | 4066篇 |
综合类 | 335篇 |
一般理论 | 24篇 |
预防医学 | 3504篇 |
眼科学 | 525篇 |
药学 | 1694篇 |
1篇 | |
中国医学 | 31篇 |
肿瘤学 | 1909篇 |
出版年
2023年 | 189篇 |
2022年 | 292篇 |
2021年 | 851篇 |
2020年 | 498篇 |
2019年 | 782篇 |
2018年 | 859篇 |
2017年 | 662篇 |
2016年 | 669篇 |
2015年 | 753篇 |
2014年 | 1066篇 |
2013年 | 1544篇 |
2012年 | 2195篇 |
2011年 | 2392篇 |
2010年 | 1247篇 |
2009年 | 1107篇 |
2008年 | 1969篇 |
2007年 | 2124篇 |
2006年 | 1996篇 |
2005年 | 1853篇 |
2004年 | 1646篇 |
2003年 | 1556篇 |
2002年 | 1416篇 |
2001年 | 279篇 |
2000年 | 218篇 |
1999年 | 245篇 |
1998年 | 260篇 |
1997年 | 206篇 |
1996年 | 160篇 |
1995年 | 174篇 |
1994年 | 147篇 |
1993年 | 138篇 |
1992年 | 166篇 |
1991年 | 152篇 |
1990年 | 174篇 |
1989年 | 115篇 |
1988年 | 109篇 |
1987年 | 120篇 |
1986年 | 118篇 |
1985年 | 131篇 |
1984年 | 85篇 |
1983年 | 82篇 |
1982年 | 58篇 |
1981年 | 72篇 |
1980年 | 64篇 |
1979年 | 78篇 |
1978年 | 58篇 |
1977年 | 46篇 |
1976年 | 40篇 |
1974年 | 48篇 |
1972年 | 38篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
Frank G. Shellock Jerrold H. Mink Andrew L. Deutsch James Fox Todd Molnar Ronald Kvitne Richard Ferkel 《Journal of magnetic resonance imaging : JMRI》1994,4(4):590-594
The effect of a newly developed patellar realignment brace was evaluated in 21 patellofemoral joints (19 patients) with patellar subluxation (13 joints with lateral subluxation and eight with medial subluxation) by using active-movement, loaded kinematic magnetic resonance (MR) imaging. Sixteen patellofemoral joints (76%) demonstrated a qualitative correction of or improvement in patellar subluxation (ie, centralization of the patella or a decrease in the displacement of the patella) after application of the brace. Four of the five “failures” occurred in patellofemoral joints that had patella alta and/or dysplastic bone anatomy. These results indicate that the patellar realignment brace was able to counteract patellar subluxation in the majority of patellofemoral joints studied, as shown by active-movement, loaded kinematic MR imaging. This brace appears to be useful for conservative treatment of patients with patellofemoral joint pain secondary to patellar malalignment and maltracking. 相似文献
22.
Kay Kathryn L Roberts Beverley J Turnbull 《The Australian journal of advanced nursing》2002,20(2):8-14
The aim of this study was to document the amount of recent change in Australian nurse academics' scholarly productivity and to investigate the influence of demographic factors such as gender, academic rank, qualifications, increase in qualifications, state of residence, university and university size. Scholarly productivity was calculated from an audit of journal articles. The findings of this study indicate that, while there has been a slight increase in scholarly productivity in the last five years, nursing still lags behind other disciplines. Scholarly productivity was found to be positively associated with highest academic qualification, academic rank and promotion. The study indicates the continuing need for senior nurse academics to provide mentoring to colleagues and foster the development of skills associated with scholarly productivity. 相似文献
23.
24.
Tissue distribution and pharmacodynamics of verapamil were evaluated during steady state intravenous (i.v.) infusion and after single dose intraperitoneal (i.p.) drug administration to female Sprague-Dawley rats. In one group of rats, verapamil was infused to a steady state concentration at which time animals were killed. Verapamil-induced decreases in mean arterial pressure (MAP) were monitored during infusion and correlated with concomitantly obtained plasma verapamil concentrations. Tissue (lung, liver, renal medulla, renal cortex, cardiac muscle, skeletal muscle, perirenal fat, brain stem, cerebral cortex, and cerebellum) and plasma samples were obtained immediately after animals were killed and verapamil and norverapamil concentrations determined. Another group of rats, after receiving i.p. verapamil, were killed at 1, 3, 5, 19, and 24 h. Elimination from each tissue evaluated was described by a first order process. Elimination half-life of verapamil was similar among plasma and tissues evaluated (1.5 to 2.2 h). The per cent verapamil not bound to plasma proteins was concentration-independent and similar between rats receiving i.p. (mean +/- S.D.) (2.28 +/- 0.72 per cent) and i.v. (2.08 +/- 0.03 per cent) verapamil. MAP and verapamil concentration in plasma (r = 0.75; p less than 0.01) and cardiac muscle (r = -0.82; p less than 0.01) were inversely correlated in a highly significant fashion during both i.v. and i.p. drug administrations. The tissue-to-plasma distribution ratio for verapamil and norverapamil was similar among animals receiving i.p. verapamil at all points of sampling, suggesting distribution equilibrium had been achieved. After steady state i.v. infusion, both verapamil and norverapamil tissue: plasma concentration ratios were greater than after i.p. administration. Higher tissue: plasma verapamil concentration ratios after i.v. administration than after i.p. administration suggest either only a pseudoequilibrium is attained after i.p. administration or that determinants of tissue distribution of racemic verapamil differ with different routes of drug administration. In these studies, MAP provided a reasonable pharmacodynamic marker for verapamil tissue and plasma concentrations. 相似文献
25.
Kathryn Nichol Sean P. Deeny Joseph Seif Kevin Camaclang Carl W. Cotman 《Alzheimer's & dementia》2009,5(4):287-294
BackgroundHuman studies on exercise, cognition, and apolipoprotein E (APOE) genotype show that ε4 carriers may benefit from regular physical activity.MethodsWe examined voluntary wheel-running, memory, and hippocampal plasticity in APOE ε3 and APOE ε4 transgenic mice at 10–12 months of age.ResultsSedentary ε4 mice exhibited deficits in cognition on the radial-arm water maze (RAWM), a task dependent on the hippocampus. Six weeks of wheel-running in ε4 mice resulted in improvements on the RAWM to the level of ε3 mice. Hippocampal brain-derived neurotrophic factor (BDNF) levels were similar in ε3 and ε4 mice, and after exercise BDNF was similarly increased in both ε3 and ε4 mice. In sedentary ε4 mice, tyrosine kinase B (Trk B) receptors were reduced by 50%. Exercise restored Trk B in ε4 mice to the level of ε3 mice, and in ε4 mice, exercise dramatically increased synaptophysin, a marker of synaptic function.ConclusionsOur results support the hypothesis that exercise can improve cognitive function, particularly in ε4 carriers. 相似文献
26.
FDA’S Perspectives on Cardiovascular Devices 总被引:1,自引:0,他引:1
Eric A. Chen Sonna M. Patel-Raman Kathryn O’Callaghan Matthew G. Hillebrenner 《Journal of cardiovascular translational research》2009,2(2):143-146
The Food and Drug Administration (FDA) decision process for approving or clearing medical devices is often determined by a
review of robust clinical data and extensive preclinical testing of the device. The mission statement for the Center for Devices
and Radiological Health (CDRH) is to review the information provided by manufacturers so that it can promote and protect the
health of the public by ensuring the safety and effectiveness of medical devices deemed appropriate for human use (Food, Drug
& Cosmetic Act, §903(b)(1, 2(C)), December 31, 2004; accessed December 17, 2008 ). For high-risk devices, such as ventricular assist devices (VADs), mechanical heart valves, stents, cardiac resynchronization
therapy (CRT) devices, pacemakers, and defibrillators, the determination is based on FDA’s review of extensive preclinical
bench and animal testing followed by use of the device in a clinical trial in humans. These clinical trials allow the manufacturer
to evaluate a device in the intended use population. FDA reviews the data from the clinical trial to determine if the device
performed as predicted and the clinical benefits outweigh the risks. This article reviews the regulatory framework for different
marketing applications related to cardiovascular devices and describes the process of obtaining approval to study a cardiovascular
device in a U.S. clinical trial. 相似文献
27.
28.
29.
30.